Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27742 | 182 | 32.2 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2356 | 3923 | I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//IBUDILAST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | I EM NEURODEGENERAT BRAIN | Address | 21 | 78% | 8% | 14 |
2 | BERAPROST SODIUM | Author keyword | 12 | 37% | 14% | 25 |
3 | NEONATE INFANT PATHOL | Address | 4 | 67% | 2% | 4 |
4 | POSTISCHEMIC DEMENTIA | Author keyword | 3 | 100% | 2% | 3 |
5 | BERAPROST | Author keyword | 3 | 19% | 7% | 12 |
6 | G ALPHAQ 11 INHIBITOR | Author keyword | 1 | 100% | 1% | 2 |
7 | PGI2 ANALOG | Author keyword | 1 | 40% | 1% | 2 |
8 | PROSTACYCLIN ANALOG | Author keyword | 1 | 16% | 3% | 5 |
9 | REHABIL ORTHOPAED | Address | 1 | 33% | 1% | 2 |
10 | CLINICAL DEATH | Author keyword | 1 | 17% | 2% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BERAPROST SODIUM | 12 | 37% | 14% | 25 | Search BERAPROST+SODIUM | Search BERAPROST+SODIUM |
2 | POSTISCHEMIC DEMENTIA | 3 | 100% | 2% | 3 | Search POSTISCHEMIC+DEMENTIA | Search POSTISCHEMIC+DEMENTIA |
3 | BERAPROST | 3 | 19% | 7% | 12 | Search BERAPROST | Search BERAPROST |
4 | G ALPHAQ 11 INHIBITOR | 1 | 100% | 1% | 2 | Search G+ALPHAQ+11+INHIBITOR | Search G+ALPHAQ+11+INHIBITOR |
5 | PGI2 ANALOG | 1 | 40% | 1% | 2 | Search PGI2+ANALOG | Search PGI2+ANALOG |
6 | PROSTACYCLIN ANALOG | 1 | 16% | 3% | 5 | Search PROSTACYCLIN+ANALOG | Search PROSTACYCLIN+ANALOG |
7 | CLINICAL DEATH | 1 | 17% | 2% | 4 | Search CLINICAL+DEATH | Search CLINICAL+DEATH |
8 | AMYLOID THERAPY | 1 | 50% | 1% | 1 | Search AMYLOID+THERAPY | Search AMYLOID+THERAPY |
9 | CANINE FEMORAL VEIN | 1 | 50% | 1% | 1 | Search CANINE+FEMORAL+VEIN | Search CANINE+FEMORAL+VEIN |
10 | DISAPPEARING PLAQUES | 1 | 50% | 1% | 1 | Search DISAPPEARING+PLAQUES | Search DISAPPEARING+PLAQUES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRK 100 | 22 | 58% | 14% | 25 |
2 | RETINA CAPILLARY PERICYTES | 6 | 80% | 2% | 4 |
3 | YM 254890 | 4 | 75% | 2% | 3 |
4 | PRECURSOR PROTEIN ACCUMULATION | 3 | 100% | 2% | 3 |
5 | STABLE PROSTACYCLIN ANALOG | 3 | 17% | 8% | 15 |
6 | GQ 11 INHIBITOR | 2 | 67% | 1% | 2 |
7 | COMPLETE CEREBRAL ISCHEMIA | 2 | 15% | 6% | 11 |
8 | EARLY ULTRASTRUCTURAL CHANGES | 1 | 100% | 1% | 2 |
9 | PGI2 ANALOG | 1 | 50% | 1% | 2 |
10 | PROSTAGLANDIN I 2 ANALOG | 1 | 18% | 4% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Alzheimer's factors in postischemic dementia | 2012 | 2 | 42 | 52% |
Novel effects of beraprost sodium on vasculatures | 2010 | 3 | 14 | 57% |
Sporadic Alzheimer's Disease Begins as Episodes of Brain Ischemia and Ischemically Dysregulated Alzheimer's Disease Genes | 2013 | 14 | 154 | 19% |
Ischemia signalling to Alzheimer-related genes | 2012 | 10 | 72 | 17% |
Beraprost - A review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension | 2002 | 39 | 84 | 23% |
Alzheimer lesions after ischemia-reperfusion brain injury | 2004 | 11 | 33 | 48% |
PHARMACODYNAMICS AND CLINICAL-STUDIES WITH BERAPROST SODIUM, A DRUG FOR PERIPHERAL VASCULAR-DISEASE | 1992 | 9 | 22 | 55% |
Alzheimer's Mechanisms in Ischemic Brain Degeneration | 2009 | 22 | 185 | 9% |
From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease | 2004 | 19 | 74 | 19% |
Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin? | 2015 | 0 | 66 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | I EM NEURODEGENERAT BRAIN | 21 | 78% | 7.7% | 14 |
2 | NEONATE INFANT PATHOL | 4 | 67% | 2.2% | 4 |
3 | REHABIL ORTHOPAED | 1 | 33% | 1.1% | 2 |
4 | DRUG DEV SUPPORTING | 1 | 50% | 0.5% | 1 |
5 | NANOBIOTECHNOL TANSZEK | 1 | 50% | 0.5% | 1 |
6 | REGENERAT MED TANSZEK | 1 | 50% | 0.5% | 1 |
7 | SEDE LITORAL | 1 | 50% | 0.5% | 1 |
8 | CARDIOLSEVERANCE CARDIOVASC HOSP | 0 | 33% | 0.5% | 1 |
9 | NUCLEO LITORAL | 0 | 33% | 0.5% | 1 |
10 | CENT UNIV VENEZUELA | 0 | 25% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000186920 | ILOPROST//WESTERN INFIRM SURG//TAPROSTENE |
2 | 0.0000133878 | EXPT THER EUT PHARMACOINFORMAT//PROSTACYCLIN SYNTHASE GENE//PROSTACYCLIN SYNTHASE |
3 | 0.0000113026 | IBUDILAST//CAS 50847 11 5//221 MIYAMA |
4 | 0.0000097647 | ONO 1301//IP RECEPTOR//EP4 RECEPTOR |
5 | 0.0000093924 | LAW INTERDISCIPLINE//1 1 DIMETHYL 4 PHENYLPIPERAZINIUM IODIDE//PLATELET PLUG |
6 | 0.0000092600 | LEUKOTRIENE C 4 SYNTHESIS DEFICIENCY//HADASSAH MED PHARMACOL//EICOSATETRAYNOIC ACID |
7 | 0.0000089308 | NIMODIPINE//EMOPAMIL//TC 81 |
8 | 0.0000078375 | 15S 15 METHYLPROSTAGLANDIN F 2 ALPHA METHYL ESTER//NON SYNCHRONOUS SHIFT//PARTIAL EXTRACT WITHDRAWAL |
9 | 0.0000073823 | SURGICAL VAGOTOMY//ACUTE SURGICAL VAGOTOMY//GASTRIC MUCOSAL BIOCHEMISTRY |
10 | 0.0000071757 | VINCONATE//DELAYED NEURONAL DEATH//GERBIL |